Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phenotypic and epigenetic heterogeneity in FGFR2-fused glial and glioneuronal tumours.
Métais A, Dangouloff-Ros V, Garcia J, Vannod-Michel Q, Csanyi M, Tauziède-Espariat A, Appay R, Maurage CA, Uro-Coste E, Meyronet D, Rigau V, Rousseau A, Chotard G, Hamelin J, Pierron G, Colin C, Ollivier M, Roques M, Provost C, Cottier JP, Pallud J, Chrétien F, Guida L, Blauwblomme T, Boddaert N, Varlet P, Edjlali M, Figarella-Branger D; contributors of the Biopathology RENOCLIP‐LOC network; of the Neuroradiological RENOCLIP‐LOC network. Métais A, et al. Among authors: meyronet d. Neuropathol Appl Neurobiol. 2024 Dec;50(6):e13014. doi: 10.1111/nan.13014. Neuropathol Appl Neurobiol. 2024. PMID: 39511841 Free PMC article.
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.
Kacimi SEO, Dehais C, Feuvret L, Chinot O, Carpentier C, Bronnimann C, Vauleon E, Djelad A, Cohen-Jonathan Moyal E, Langlois O, Campone M, Ducloie M, Noel G, Cuzzubbo S, Taillandier L, Ramirez C, Younan N, Menei P, Dhermain F, Desenclos C, Ghiringhelli F, Bourg V, Ricard D, Faillot T, Appay R, Tabouret E, Nichelli L, Mathon B, Thomas A, Tran S, Bielle F, Alentorn A, Iorgulescu JB, Boëlle PY, Labreche K, Hoang-Xuan K, Sanson M, Idbaih A, Figarella-Branger D, Ducray F, Touat M; POLA Network. Kacimi SEO, et al. J Clin Oncol. 2024 Oct 2:JCO2400049. doi: 10.1200/JCO.24.00049. Online ahead of print. J Clin Oncol. 2024. PMID: 39356975
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.
Esparragosa Vazquez I, Sanson M, Chinot OL, Fontanilles M, Rivoirard R, Thomas-Maisonneuve L, Cartalat S, Tabouret E, Appay R, Bonneville-Levard A, Darlix A, Meyronet D, Barritault M, Gueyffier F, Remontet L, Maucort-Boulch D, Honnorat J, Dehais C, Ducray F; POLA Network. Esparragosa Vazquez I, et al. Among authors: meyronet d. Neurooncol Adv. 2024 May 27;6(1):vdae078. doi: 10.1093/noajnl/vdae078. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38855053 Free PMC article.
Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
Picart T, Pallud J, Berthiller J, Dumot C, Berhouma M, Ducray F, Armoiry X, Margier J, Guerre P, Varlet P, Meyronet D, Metellus P, Guyotat J; Members of RESECT study group:. Picart T, et al. Among authors: meyronet d. J Neurosurg. 2023 Oct 13;140(4):987-1000. doi: 10.3171/2023.7.JNS231170. Print 2024 Apr 1. J Neurosurg. 2023. PMID: 37856381 Clinical Trial.
Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.
Guidara S, Seyve A, Poncet D, Leonce C, Bringuier PP, McLeer A, Sturm D, Cartalat S, Picart T, Ferrari A, Hench J, Frank S, Meyronet D, Ducray F, Barritault M. Guidara S, et al. Among authors: meyronet d. J Neurooncol. 2024 Sep;169(2):391-398. doi: 10.1007/s11060-024-04733-z. Epub 2024 Jun 27. J Neurooncol. 2024. PMID: 38937309
CNS Embryonal Tumor with PLAGL Amplification, a New Tumor Type in Children and Adolescents: Insights from a Comprehensive MRI Analysis.
Tietze A, Bison B; European Society for Paediatric Oncology (SIOPE)-Brain Tumour Group; Engelhardt J, Fenouil T, Figarella-Branger D, Goebell E, Hakumäki J, Koscielniak E, Ludlow LE, Meyronet D, Nyman P, Øra I, Pesola J, Rauramaa T, Reddingius RE, Samuel D, Sexton-Oates A, Vasiljevic A, Wefers AK, Zamecnik J, Jones D, Keck MK, von Hoff K. Tietze A, et al. Among authors: meyronet d. AJNR Am J Neuroradiol. 2024 Sep 13:ajnr.A8496. doi: 10.3174/ajnr.A8496. Online ahead of print. AJNR Am J Neuroradiol. 2024. PMID: 39271290
Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategies.
Trecourt A, Cottinet PJ, Donzel M, Favretto M, Bancel B, Decaussin-Petrucci M, Traverse-Glehen A, Devouassoux-Shisheboran M, Meyronet D, Belleannée G, Rullier A, Lê MQ, Rival G, Grinberg D, Tilmant C, Gaillot-Durand L; TEAP; EcoPath groups. Trecourt A, et al. Among authors: meyronet d. Ann Diagn Pathol. 2023 Dec;67:152210. doi: 10.1016/j.anndiagpath.2023.152210. Epub 2023 Sep 16. Ann Diagn Pathol. 2023. PMID: 37734347 Free article. No abstract available.
Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases.
Gkasdaris G, Berthiller J, Guyotat J, Jouanneau E, Gallet C, Meyronet D, Thomas L, Cartalat S, Seyve A, Honnorat J, Ducray F, Picart T. Gkasdaris G, et al. Among authors: meyronet d. Cancers (Basel). 2024 Oct 12;16(20):3465. doi: 10.3390/cancers16203465. Cancers (Basel). 2024. PMID: 39456559 Free PMC article.
154 results